Jancinová V, Nosál R
Centre of Physiological Sciences, Slovak Academy of Sciences, Bratislava, Czechoslovakia.
Thromb Res. 1989 Jun 15;54(6):687-98. doi: 10.1016/0049-3848(89)90133-3.
The dose-dependent inhibition of thrombin stimulated platelet aggregation due to beta-adrenoceptor blocking drugs followed the rank order of potency: propranolol greater than alprenolol greater than metipranolol and correlated with arachidonic acid (3H-AA) liberation. Atenolol which slightly potentiated stimulated aggregation increased also the liberation of 3H-AA from membrane phospholipids of isolated platelets. Stimulation of platelets resulted in decreased 3H-AA incorporation into phosphatidylcholine, phosphatidylinositol and phosphatidic acid and increased incorporation into phosphatidylethanolamine and phosphatidylserine. Alprenolol, metipranolol and propranolol enhanced the incorporation of 3H-AA into phosphatidylcholine of stimulated platelets.
β-肾上腺素受体阻断药对凝血酶刺激的血小板聚集的剂量依赖性抑制作用,其效力顺序为:普萘洛尔>阿普洛尔>美替洛尔,且与花生四烯酸(3H-AA)释放相关。阿替洛尔轻度增强刺激的聚集作用,同时也增加了分离血小板膜磷脂中3H-AA的释放。血小板的刺激导致3H-AA掺入磷脂酰胆碱、磷脂酰肌醇和磷脂酸减少,而掺入磷脂酰乙醇胺和磷脂酰丝氨酸增加。阿普洛尔、美替洛尔和普萘洛尔增强了3H-AA掺入受刺激血小板的磷脂酰胆碱。